Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0155339 (Brown)
 12,436 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Even though autogenous nerve grafts are used frequently, there is little information concerning cell survival rates and migration patterns, following peripheral nerve grafting. Labeling techniques with a vital fluorescent stain (PKH-26, Zynaxis Cell Science, Malvern, PA) allow cell migrations from both the nerve graft and host nerve to be tracked for up to 45 days from the time of nerve transplantation. With this labeling technique, two phases of nerve graft incorporation were identified, early and late, in an animal model using inbred Lewis and Brown-Norway rats. In genetically identical Lewis rats, isografts were performed as a means of modeling the autografts used clinically. At approximately 3 days after isogeneic transplantation, with the proximal host nerve end labeled, there was an early migration of host cells from the proximal nerve end into the epineural tissue of the nerve graft. At 25 days, a late phase was evident, with fluorescent labeling of host cells into the perineural and endoneural tissues. When the nerve grafts were labeled, the label persisted for up to 45 days, indicating viability of the graft. Cells migrated from the labeled nerve graft into the distal host nerve segment. Cellular migration from peripheral nerve tissue, following allograft transplantation, was initially similar to the isograft studies. But after 25 days, with the proximal host nerve end labeled, a significant decrease in the labeled host cells migrating into the graft was noted (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Cell viability and migration in nerve isografts and allografts. 816 3

The extravasation and sequestration of Ag-reactive T lymphocytes into vascularized organ allografts depend on a cascade of complex interactions among circulating lymphocytes, endothelial cells, and extracellular matrix proteins. Ag-activated donor-specific CD4 T cells are major initiators and effectors in the allograft rejection response. Interfering with the intragraft homing of activated CD4 T cells may represent a novel therapeutic approach in transplant recipients. We have developed a FACS-based short-term homing assay that allows tracing in vitro-generated Ag-reactive CD4 T cells after adoptive transfer in test rat recipients. Allospecific cell lines were preincubated with anti-alpha(4)beta(1) or anti-alpha(L)beta(2) mAb, because of enhanced expression of both integrin receptors after alloactivation. The pretreated Lewis(BN) lymphocytes were carboxyfluorescein diacetate succinimidyl ester labeled and adoptively transferred into Lewis rat recipients of Brown Norway kidney allografts. The injection of equal numbers of PKH-26-labeled untreated cells allowed quantitative comparison of both populations in the same animal. Ex vivo treatment with anti-alpha(4)beta(1) mAb diminished intragraft infiltration of adoptively transferred T cells by 85% in a donor-specific fashion. In contrast, treatment with anti-alpha(L)beta(2) mAb did not affect intragraft cell sequestration. Hence, blocking alpha(4)beta(1) integrin interactions represents a novel strategy in preventing local intragraft recruitment of Ag-reactive CD4 T cells in transplant recipients.
 ...
PMID:Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is alpha 4 beta 1 but not alpha L beta 2 integrin dependent. 1112 42